Farxiga approved in the US to reduce the risk of hospitalisation for heart failure in patients with type-2 diabetes Read more
Nucala is the first biologic approved in the US for six to 11-year-old children with severe eosinophilic asthma Read more
Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with CKD Read more
Lynparza Phase III PAOLA-1 trial met primary endpoint as 1st-line maintenance treatment with bevacizumab for advanced ovarian cancer Read more
Boehringer and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies Read more